<DOC>
	<DOCNO>NCT00004100</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know regimen chemotherapy effective non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness two regimen chemotherapy treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare gemcitabine plus vinorelbine vs standard chemotherapy contain cisplatin term effect quality life patient stage IIIB IV non-small cell lung cancer . II . Compare effect regimens overall survival patient . III . Compare toxic effect regimens patient . IV . Compare effect regimens rate objective response patient . OUTLINE : This randomize , multicenter study . Patients stratify accord center , stage disease ( IIIB v IV ) , performance status ( 0 vs 1 v 2 ) . Patients randomize one two treatment arm . Arm I : Patients receive cisplatin IV day 1 either gemcitabine IV vinorelbine IV day 1 8 . Arm II : Patients receive gemcitabine IV vinorelbine IV day 1 8 . Treatment repeat every 21 day 6 course . Quality life assess prior therapy course chemotherapy fourth course . PROJECTED ACCRUAL : A total 500 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven nonsmall cell lung cancer Stage IV OR Stage IIIB supraclavicular lymph node metastases and/or pleural effusion curable radiotherapy Measurable evaluable disease No CNS metastases PATIENT CHARACTERISTICS : Age : Under 70 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Neutrophil count least 2000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10 g/dL Hepatic : ( Unless cause liver metastasis ) Bilirubin great 1.25 time upper limit normal ( ULN ) SGOT SGPT great 1.25 time ULN Renal : Creatinine great 1.25 time ULN Other : No prior concurrent malignancy except basal squamous cell skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Concurrent palliative radiotherapy allow Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>